SLCTR/2022/014已完成未知
Randomized control clinical trial to assess the effect of meditation on selected clinical outcomes in patients with Parkinson’s disease and epilepsy
World Bank, AHEAD 81 grant0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Inclusion criteria for Parkinson’s disease group
- •1)Diagnosis of PD according to Movement Disorder Society clinical diagnostic criteria for Parkinson Disease
- •2)Patients in Hoehn and Yahr stages I–III
- •3)Optimally treated with PD medication and unlikely to require anti-PD medication adjustments in the next one month
- •4)Stable dose of all medications for 30 days prior to inclusion
- •5)Lack of cognitive dysfunction as evidenced by the Montreal Cognitive Assessment Test (MoCA) (score greater than or equal to 26)
- •6)No known unstable or life-threatening concomitant disease
- •7)No previous meditation training and or regular practice
- •8)Commitment to attend meditation training sessions both onsite and online and to perform the prescribed daily homework of meditation.
- •Inclusion criteria for Epilepsy group
- •1)Patients aged 18 years or older
- •2)Having a clinical diagnosis of medication-resistant epilepsy
- •3)Seizure frequency of 4 or more seizures per month
- •4)On a stable antiepileptic drug regimen for the prior ?30 days
- •5)No history of status epilepticus within the previous 6 months
- •6)Not pregnant or planning pregnancy
- •7)Able to maintain a seizure diary independently
- •8)No known unstable or life-threatening concomitant disease
- •9)No previous meditation training or regular practice
- •10)Commitment to attend meditation training sessions both onsite and online and to perform the prescribed daily homework of meditation
排除标准
- •Exclusion criteria for Parkinson disease group
- •1)Usage of neuroleptics or other drugs that induce parkinsonism within 60 days prior to inclusion
- •2)Patients with psychotic symptoms
- •3)Atypical parkinsonian syndromes
- •Exclusion criteria for Epilepsy group
- •1.) Patients with coexisting psychiatric diagnosis
- •2.) Patients with intellectual impairment
- •3.) Alcohol or substance dependence
研究者
相似试验
尚未招募
2 期
Improvement in treatment of hypothyroidism using slow-release LiothyronineHypothyroidism.Hypothyroidism, unspecifiedE03.9IRCT20100922004794N13Dorsa Pharmaceutical Company44
招募中
2 期
A clinical study to evaluate the efficacy of ayurvedic therapeutics on Pitta Vidagdha drishti w.s.r to Dry Age related Macular DegeneratioCTRI/2020/06/026080ational Institute of Ayurveda
尚未招募
不适用
Study to evaluate efficacy of Ikshumool Ghanvati with Himplasia tablet in the management of Vatashtheela(Benign prostatic hyperplasia).CTRI/2019/04/018542PDEAs college of ayurved and research centre
招募中
不适用
Controlled Randomized Clinical Trial to assess Efficacy of Deep Brain Stimulation (DBS) of the slMFB in Patients with Treatment Resistant Major DepressioF33.2F33.3F33.8F33.9Recurrent depressive disorder, current episode severe without psychotic symptomsRecurrent depressive disorder, current episode severe with psychotic symptomsOther recurrent depressive disordersRecurrent depressive disorder, unspecifiedDRKS00014947niversitätsklinikum Freiburg47
招募中
不适用
Rotational Thromboelastometry (ROTEM)-guided blood product in patients with cirrhosis undergoing invasiveproceduresCoagulopathyACTRN12619000644167Alfred Health50